KEY PRODUCTS
HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
01 1HTL Javené FR
01 1Sodium hyaluronate, Intrinsic viscosity: 1.7 m3/kg, 1.9 m3/kg, 2.4 m3/kg, 2.8 m3/kg, or 3.5 m3/kg, by fermentation, for parenteral administration including intra-articular use and intra-ocular use
01 1France
01 1Valid
HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
Sodium Hyaluronate, Intrinsic Viscosity: 1.7 M3/...
Certificate Number : CEP 2001-385 - Rev 09
Status : Valid
Issue Date : 2024-07-24
Type : Chemical
Substance Number : 1472
20
Htl Javené Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
One of their significant offerings is Sodium hyaluronate, Intrinsic viscosity: 1.7 m3/kg, 1.9 m3/kg, 2.4 m3/kg, 2.8 m3/kg, or 3.5 m3/kg, by fermentation, for parenteral administration including intra-articular use and intra-ocular use, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2001-385 - Rev 09
This Chemical Type CEP, issued on July 24, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1472 associated with this CEP further emphasizes
